Patents by Inventor Hajime Otani

Hajime Otani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10052354
    Abstract: It is to provide a composition derived from lactic acid bacteria having an anti-allergic effect (an effect of suppressing allergic symptoms such as hay fever) synergistically, and a food product, pet food, etc. containing the composition. It is to prepare a composition having an anti-allergic action, containing Lactobacillus crispatus KT-11 strain, KT-23 strain, or KT-25 strain bacterial cells and viable bacteria, dead bacteria, or a processed product of bacterial cells of other lactic acid bacteria belonging to the genus Lactobacillus, genus Bifidobacterium, genus Leuconostoc, genus Enterococcus, genus Pediococcus, etc. at a biomass-converted ratio of 99:1 to 50:50, preferably 99:1 to 75:25.
    Type: Grant
    Filed: March 4, 2011
    Date of Patent: August 21, 2018
    Assignee: KITII CO., LTD.
    Inventors: Keisuke Tobita, Hajime Otani
  • Publication number: 20130045291
    Abstract: It is to provide a composition derived from lactic acid bacteria having an anti-allergic effect (an effect of suppressing allergic symptoms such as hay fever) synergistically, and a food product, pet food, etc. containing the composition. It is to prepare a composition having an anti-allergic action, containing Lactobacillus crispatus KT-11 strain, KT-23 strain, or KT-25 strain bacterial cells and viable bacteria, dead bacteria, or a processed product of bacterial cells of other lactic acid bacteria belonging to the genus Lactobacillus, genus Bifidobacterium, genus Leuconostoc, genus Enterococcus, genus Pediococcus, etc. at a biomass-converted ratio of 99:1 to 50:50, preferably 99:1 to 75:25.
    Type: Application
    Filed: March 4, 2011
    Publication date: February 21, 2013
    Applicant: KITII CO., LTD.
    Inventors: Keisuke Tobita, Hajime Otani
  • Publication number: 20050220801
    Abstract: An object of the present invention is to provide a peptide with superior immuno-enhancing activities, which comprises particular amino acid sequence, and an immuno-enhancing agent comprising such a peptide. The present invention relates to the immuno-enhancing agent comprising a peptide consisting of the following amino acid sequence (I): Q1-SerP-X-SerP-Q2 (I); wherein, SerP represents the phosphoserine residue, X represents one to three of any amino acid residues, and either of Q1 or Q2 dose not exist or neither of them exists, or Q1 and Q2 are independently at least one of any amino acid residue.
    Type: Application
    Filed: March 11, 2002
    Publication date: October 6, 2005
    Inventors: Hajime Otani, Yasuhito Tashiro, Michihisa Sugihara